Back to Search Start Over

Experimental Phaeohyphomycosis of Curvularia lunata .

Authors :
Al-Odaini N
Pan KS
Liao LW
Mo NF
Jiang ZW
Li TT
Li XY
He XJ
Zheng DY
Cao CW
Source :
Journal of clinical medicine [J Clin Med] 2022 Sep 14; Vol. 11 (18). Date of Electronic Publication: 2022 Sep 14.
Publication Year :
2022

Abstract

Originally considered to be a plant pathogen, reports of phaeohyphomycosis due to Curvularia lunata ( C. lunata ) in animals and humans are increasing. However, studies on the pathogenesis, virulence, and epidemiology of C. lunata have rarely been discussed. In the present study, BALB/c mice were experimentally inoculated with C. lunata suspension by different routes and the course of infection was evaluated. In addition, the in vitro antifungal susceptibility of C. lunata against six commonly used antifungals was evaluated using the microdilution method. Inoculation resulted in skin lesions in animals inoculated intraperitonially and subcutaneously. Infection was confirmed by both mycological and histopathologic examination. C. lunata spores and hyphae were detected in the histopathologic sections stained with hexamine silver staining. In addition, voriconazole (VRC) demonstrated greater activity against C. lunata when compared to the other antifungals, whereas fluconazole (FLC) was the least active antifungal with a minimum inhibitory concentration (MIC) range of 8-16 μg/mL. Further studies are necessary to understand the pathogenicity of C. lunata and uncover the mystery of this fungus.

Details

Language :
English
ISSN :
2077-0383
Volume :
11
Issue :
18
Database :
MEDLINE
Journal :
Journal of clinical medicine
Publication Type :
Academic Journal
Accession number :
36143037
Full Text :
https://doi.org/10.3390/jcm11185393